Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics Inks Canadian Distribution Deal With D-Mark Bioscences

NEW YORK – S2 Genomics has entered into a distribution agreement with D-Mark Biosciences in Canada for the promotion, sale, and support of S2's Singulator 100 system and associated products for single-cell genomics and cell biology applications.

The Singulator 100 system isolates single cells or nuclei from solid tissue samples, enabling the production of high-quality, single-cell data from difficult tissue types. The system features single-use disposable cartridges and proprietary reagents to automate tissue dissociation, and allows users to create their own dissociation protocols, use their own reagents, and dissociate tissue at low temperature to minimize changes to cell transcriptomes.

"Canada is experiencing significant growth in single-cell genomic and cell biology markets, creating a need for improved single-cell preparation solutions," S2 Genomics CEO Stevan Jovanovich said in a statement, adding that partnering with D-Mark represents a "significant milestone" for the company.

Livermore, California-based S2 has previously forged a collaboration with Dolomite Bio on automated single-cell library prep from tissues; partnered with Japan's RIKEN Center for Integrated Medical Sciences on single-cell genomics applications; and inked distribution agreements in the Asia-Pacific region with Scrum, PharmiGene, LnCBio, Thunderbio Science, and TrendBio.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.